Haripriyaa Pharmaceuticals Private Limited
About Haripriyaa Pharmaceuticals Private Limited
Data last updated:
Haripriyaa Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2019PTC130696. Its GSTIN is 36AAECH8218G1ZK (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajitha Manipuri and Omprakash Manpuri.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D.No 1 – 2 – 234/33/A Sbh Colony Ashok Nagar, Hyderabad, Telangana, India – 500020.
Court records list 4 cases involving the company, including 4 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Haripriyaa Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD.No 1 – 2 – 234/33/A Sbh Colony Ashok Nagar, Hyderabad, Telangana, India – 500020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Haripriyaa Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Haripriyaa Pharmaceuticals Private Limited
FY 2024 filings availableHaripriyaa Pharmaceuticals Private Limited reported revenue of ₹1,791 for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Haripriyaa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Haripriyaa Pharmaceuticals Private Limited
Haripriyaa Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajitha Manipuri Also directs: Haripriyaa Builders and Developers LLP | Director | 19 Feb 2019 | 7 Years 8 Months | Current |
| Omprakash Manpuri Also directs: Haripriyaa Builders and Developers LLP | Additional Director | 19 Sep 2019 | 7 Years 1 Months | Current |
Peer comparison
Haripriyaa Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anya Polymers Private Limited | ₹1,960 (FY 2025) | -100.0% | New Delhi, Delhi, India | |||
| Donnel Healthcare Private Limited | ₹1,877 (FY 2025) | -100.0% | Bhiwadi, Rajasthan, India | |||
| Exprohelp Technosoft Private Limited | ₹1,832 (FY 2024) | -100.0% | Lucknow, Uttar Pradesh, India | |||
| U. P. Pharmacy Limited | ₹1,794 (FY 2025) | 1347.0% | New Delhi, Delhi, India | |||
| Amit Heterochem Labs India Limited | ₹1,794 (FY 2024) | -100.0% | Ghaziabad, Uttar Pradesh, India | |||
| Haripriyaa Pharmaceuticals Private Limitedthis company | ₹1,791 (FY 2024) | Hyderabad, Telangana, India | ||||
| Watika Pharmaceuticals (OPC) Private Limited | ₹1,782 (FY 2024) | New Delhi, Delhi, India | ||||
| Herbage Pharmaceuticals Private Limited | ₹1,750 (FY 2024) | 9.0% | Noida, Uttar Pradesh, India | |||
| Skizze Pharmaceuticals Private Limited | ₹1,729 (FY 2025) | Bangalore, Karnataka, India | ||||
| Rakare Lifesciences Private Limited | ₹1,720 (FY 2025) | -100.0% | Hyderabad, Telangana, India | |||
| Palmanjela Pharmaceuticals Private Limited | ₹1,646 (FY 2024) | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Haripriyaa Pharmaceuticals Private Limited, buy the company report.
Auditor
Haripriyaa Pharmaceuticals Private Limited is audited by garapati & associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| garapati & associates | FY 2023 | 251674 |
Shareholding
The shareholding of Haripriyaa Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Haripriyaa Pharmaceuticals Private Limited, buy the company report.
Legal cases
Haripriyaa Pharmaceuticals Private Limited has 4 court cases on record: 4 filed against it. 1 case is pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 1 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Lendingkart Finance Limited | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Lendingkart Finance Limited | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by Lendingkart Finance Limited | Disposed |
To see the full case history of Haripriyaa Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Haripriyaa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Haripriyaa Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECH8218G1ZK | Telangana | Active | 23 Sep 2019 |
To see the full GST registrations and return filing status of Haripriyaa Pharmaceuticals Private Limited, buy the company report.
Recent activity
Haripriyaa Pharmaceuticals Private Limited has 6 board changes on record since 2019: 4 appointments and 2 cessations. The latest: Laxman Goud Gajarla ceased to be Director on 19 Sep 2019.
Frequently asked questions
Haripriyaa Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 February 2019 (7+ years old) and is registered under CIN U24239TG2019PTC130696.
Haripriyaa Pharmaceuticals has 2 current directors:
- Rajitha Manipuri - Director
- Omprakash Manpuri - Additional Director
The latest financial statements of Haripriyaa Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Haripriyaa Pharmaceuticals is 36AAECH8218G1ZK, registered in Telangana.
The CIN (Corporate Identification Number) of Haripriyaa Pharmaceuticals is U24239TG2019PTC130696. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Haripriyaa Pharmaceuticals has 4 court cases on record: 4 filed against it. 1 is pending.
Haripriyaa Pharmaceuticals was incorporated on 19 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Haripriyaa Pharmaceuticals by revenue are Anya Polymers Private Limited, Donnel Healthcare Private Limited, Exprohelp Technosoft Private Limited, U. P. Pharmacy Limited, Amit Heterochem Labs India Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Laxman Goud Gajarla ceased to be Director on 19 Sep 2019. Omprakash Manpuri was appointed as Additional Director on 19 Sep 2019. Prahalad Gottipamula ceased to be Director on 19 Sep 2019. Haripriyaa Pharmaceuticals has 6 board changes on record in total.
The registered office of Haripriyaa Pharmaceuticals is at D.No 1 – 2 – 23433A Sbh Colony Ashok Nagar, Hyderabad, Telangana, India – 500020.
Haripriyaa Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
